Stay updated on Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Sign up to get notified when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.

Latest updates to the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page
- Check6 days agoChange DetectedThe page's revision label changed from v3.5.3 to v3.5.4, indicating a backend/platform update rather than content changes to the record history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the Record History page, indicating a new version of the study record was published.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed from the record history.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 in the record history.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded a new revision entry v3.4.3 and removed the previous revision v3.4.2 from the history log.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior government-funding and operating-status notice (Revision: v3.4.1) from the page.SummaryDifference0.6%

Stay in the know with updates to Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eftilagimod Combo with Pembrolizumab in HNSCC Clinical Trial page.